How do the provisions I CBD and IU compare with regard to biotechnology intellectual property?

The provisions of the Convention on Biological Diversity (CBD) and the International Undertaking (IU) on Plant Genetic Resources for Food and Agriculture (PGRFA) differ significantly from those related to biotechnology intellectual property (IP). While both agreements address issues related to access to genetic resources and benefit-sharing, they have distinct objectives, scopes, and mechanisms for regulating biotechnology IP.

1. Convention on Biological Diversity (CBD):

   The CBD, adopted in 1992, aims to promote the conservation and sustainable use of biodiversity and ensure the fair and equitable sharing of benefits arising from the utilization of genetic resources. The CBD recognizes the sovereign rights of countries over their biological resources and emphasizes the need for prior informed consent (PIC) and mutually agreed terms (MAT) for accessing genetic resources and traditional knowledge.

   In the context of biotechnology IP, the CBD seeks to address concerns related to biopiracy and the misappropriation of genetic resources and traditional knowledge. It calls for the development of legal and policy frameworks to ensure that benefits derived from the commercialization of genetic resources and associated traditional knowledge are shared fairly and equitably with the countries of origin and indigenous and local communities.

   However, the CBD does not provide specific provisions or mechanisms for regulating biotechnology IP rights, such as patents on genetic sequences or genetically modified organisms (GMOs). Instead, it encourages countries to incorporate CBD principles and objectives into their national laws and policies related to biotechnology, intellectual property, and access and benefit-sharing (ABS).

2. International Undertaking (IU) on Plant Genetic Resources for Food and Agriculture (PGRFA):

   The IU, established in 1983 under the auspices of the Food and Agriculture Organization (FAO), aims to ensure the conservation, exchange, and sustainable use of plant genetic resources for food and agriculture. The IU emphasizes the importance of maintaining the genetic diversity of cultivated plants and crops to enhance food security, adapt to climate change, and support agricultural innovation and development.

   In the context of biotechnology IP, the IU addresses issues related to the intellectual property rights over plant genetic resources and their utilization in breeding and biotechnological research. It recognizes the need to balance the interests of breeders, farmers, and the public in accessing and using plant genetic resources, while also promoting innovation and investment in agricultural research and development.

   The IU includes provisions for facilitating access to plant genetic resources for breeding and research purposes, as well as mechanisms for sharing the benefits arising from the commercialization of improved plant varieties. It encourages countries to establish national policies and legal frameworks to support the conservation, exchange, and sustainable use of plant genetic resources and promote equitable benefit-sharing among stakeholders.

In summary, while both the CBD and IU address issues related to access to genetic resources and benefit-sharing, their provisions and mechanisms for regulating biotechnology intellectual property differ. The CBD focuses on ensuring fair and equitable benefit-sharing from the utilization of genetic resources and traditional knowledge, while the IU emphasizes the conservation, exchange, and sustainable use of plant genetic resources for food and agriculture, including the regulation of biotechnology IP rights in the context of agricultural research and breeding.